Clinical Trial Update: DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit [NA]

View source ↗

Summary

This document presents the clinical performance study protocol for the Therascreen KRAS RGQ PCR Kit, a diagnostic test used in metastatic colorectal cancer to d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Therascreen KRAS RGQ PCR Kit (KRAS RGQ PCR Kit)

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Metastatic Colorectal Cancer (mCRC) | NA | Status: RECRUITING